Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Oka, Masahiro ^a   Sakaguchi, Masanobu ^a   Okada, Taro ^a   Nagai, Hiroshi ^a   Ozaki, Michitaka ^b   Yoshioka, Toyo ^a   Inoue, Hiroshi ^c   Mukaida, Naofumi ^c   Kikkawa, Ushio ^d   Nishigori, Chikako ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d KOBE UNIVERSITY   (Japan)

Author keywords

IL 8; Luciferase assay; Melanoma; STAT3; Transcription

Indexed keywords

INTERLEUKIN 8; LUCIFERASE; STAT3 PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA CELL; PROMOTER REGION; PROTEIN PHOSPHORYLATION;

ADENOVIRIDAE; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-8; LUCIFERASES; MELANOMA; PHOSPHORYLATION; PLASMIDS; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 77954852993     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00972.x     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin 2008, 58:71-96.
2. Espey D K, Wu X C, Swan J. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007, 110:2119-2152.
3. Shih I M, Herlyn M. Role of growth factors and their receptors in the development and progression of melanoma. J Invest Dermatol 1993, 100(Suppl. 2):196S-203S.
4. Halaban R. Growth factors and melanomas. Semin Oncol 1996, 23:673-681.
5. Oppenheim J J, Zachariae C O, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene " intercrine" cytokine family. Annu Rev Immunol 1991, 9:617-648.
6. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994, 55:97-197.
7. Koch A E, Polverini P J, Kunkel S L. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
8. Strieter R M, Polverini P J, Kunkel S L. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995, 270:27348-27357.
9. Zachariae C O, Thestrup-Pedersen K, Matsushima K. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol 1991, 97:593-599.
10. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994, 56:554-558.
11. Colombo M P, Maccalli C, Mattei S, Melani C, Radrizzani M, Parmiani G. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines. Melanoma Res 1992, 2:181-189.
12. Bennicelli J L, Guerry D IV. Production of multiple cytokines by cultured human melanomas. Exp Dermatol 1993, 2:186-190.
13. Ciotti P, Rainero M L, Nicolò G. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res 1995, 5:41-47.
14. Singh R K, Varney M L, Bucana C D, Johansson S L. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin. Melanoma Res 1999, 9:383-387.
15. Gutman M, Even-Sapir E, Merimsky O, Trejo L, Klausner J M, Lev-Chelouche D. The role of interleukin-8 in the initiation and progression of human cutaneous melanoma. Anticancer Res 2002, 22:3395-3398.
16. Scheibenbogen C, Möhler T, Haefele J, Hunstein W, Keilholz U. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res 1995, 5:179-181.
17. Singh R K, Gutman M, Radinsky R, Bucana C D, Fidler I J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994, 54:3242-3247.
18. Singh R K, Gutman M, Reich R, Bar-Eli M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res 1995, 55:3669-3674.
19. Gebhardt C, Averbeck M, Viertel A. Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion. Exp Dermatol 2007, 16:636-643.
20. Luca M, Huang S, Gershenwald J E, Singh R K, Reich R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997, 151:1105-1113.
21. Schaider H, Oka M, Bogenrieder T. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 2003, 103:335-343.
22. Patel P S, Varney M L, Dave B J, Singh R K. Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J Interferon Cytokine Res 2002, 22:427-435.
23. Akira S, Nishio Y, Inoue M. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994, 77:63-71.
24. Zhong Z, Wen Z, Darnell J E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264:95-98.
25. Ruff-Jamison S, Zhong Z, Wen Z, Chen K, Darnell J E, Cohen S. Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver. J Biol Chem 1994, 269:21933-21935.
26. Darnell J E. STATs and gene regulation. Science 1997, 277:1630-1635.
27. Horvath C M, Wen Z, Darnell J E. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 1995, 15:984-994.
28. Sasse J, Hemmann U, Schwartz C. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol 1997, 17:4677-4686.
29. Bromberg J, Chen X. STAT proteins: signal tranducers and activators of transcription. Methods Enzymol 2001, 333:138-151.
30. Levy D E, Lee C K. What does Stat3 do? J Clin Invest 2002, 109:1143-1148.
31. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
32. Niu G, Bowman T, Huang M. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 2002, 21:7001-7010.
33. Hsu M Y, Elder D E, Herlyn M. The Wistar melanoma (WM) cell lines. s. Human Cell Cultur 1999, 259-274. Mastes J R W, Palsson B, eds, London, Kluwer Academic Publishers
34. Haga S, Terui K, Zhang H Q. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003, 112:989-998.
35. Ikuta S, Edamatsu H, Li M, Hu L, Kataoka T. Crucial role of phospholipase Cε in skin inflammation induced by tumor-promoting phorbol ester. Cancer Res 2008, 68:64-72.
36. Oka M, Hitomi T, Okada T. Dual regulation of phospholipase D1 by protein kinase Cαin vivo. Biochem Biophys Res Commun 2002, 294:1109-1113.
37. Murayama T, Ohara Y, Obuchi M. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-γB-binding sites of the interleukin-8 gene. J Virol 1997, 71:5692-5695.
38. Sonoda H, Okada T, Jahangeer S, Nakamura S. Requirement of phospholipase D for ilimaquinone-induced Golgi membrane fragmentation. J Biol Chem 2007, 282:34085-34092.
39. Roebuck K A. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999, 19:429-438.
40. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989, 143:1366-1371.
41. Voelcker V, Gebhardt C, Averbeck M. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol 2008, 17:100-107.
42. Seidel M, Milocco L H, Lamb P, Darnell J E, Stein R B, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995, 92:3041-3045.
43. Trevino J G, Gray M J, Nawrocki S T. Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. Angiogenesis 2006, 9:101-110.
44. Gharavi N M, Alva J A, Mouillesseaux K P. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem 2007, 282:31460-31468.
45. de la Iglesia N, Konopka G, Lim K L. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 2008, 28:5870-5878.
46. Melnikova V O, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res 2006, 19:395-405.
47. Xie T, Wei D, Liu M. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004, 23:3550-3560.
48. Xie T, Huang F J, Aldape K D. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006, 66:3188-3196.